Challenges in the Development of Continuous Processes for Vaccines
Posted on November 3, 2016
By: Daniel C. Vellom, PhD, Senior Director, Global Technology & Innovation
Sanofi Pasteur Biologics, Inc.
Abstract The development and application of continuous manufacturing processes for vaccines presents both great opportunity as well as significant challenges, both technical and cultural, for the global industry. The key drivers are manufacturing capacity and flexibility, speed to market, and improv...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Daniel C. Vellom, PAT, Process Analytical Technology, QbD, Quality by Design, vaccines
Related Product Videos
The new Kleenpak® Presto genderless sterile connector is as simple as that!
Related Products
Sartorius Stedim Biotech presents the first fully integrated upstream platformSingle-use Xcellerex™ XDUO 2500 mixing system - GE Healthcare Life Sciences
Finesse
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
